Gut microbiota composition explains more variance in the host cardiometabolic risk than genetic ancestry

AbstractBackgroundCardiometabolic affections greatly contribute to the global burden of disease. The susceptibility to these conditions associates with the ancestral genetic composition and gut microbiota. However, studies explicitly testing associations between genetic ancestry and gut microbes are rare. We examined whether the ancestral genetic composition was associated with gut microbiota, and split apart the effects of genetic and non-genetic factors on host health.ResultsWe performed a cross-sectional study of 441 community-dwelling Colombian mestizos from five cities. We characterized the host genetic ancestry using 40 ancestry informative markers and gut microbiota through 16S rRNA gene sequencing. We measured variables related to cardiometabolic health (adiposity, blood chemistry and blood pressure), diet (calories, macronutrients and fiber) and lifestyle (physical activity, smoking and medicament consumption). The ancestral genetic composition of the studied population was 67±6% European, 21±5% Native American and 12±5% African. While we found limited evidence of associations between genetic ancestry and gut microbiota or disease risk, we observed a strong link between gut microbes and cardiometabolic health. Multivariable-adjusted linear models indicated that gut microbiota was more likely to explain variance in host health than genetic ancestry. Further, we identified 9 OTUs associated with increased disease risk and 11 with decreased risk.ConclusionsGut microbiota seems to be more meaningful to explain cardiometabolic disease risk than genetic ancestry in this mestizo population. Our study suggests that novel ways to control cardiometabolic disease risk, through modulation of the gut microbial community, could be applied regardless of the genetic ancestry of the intervened population.

Download Full-text

Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors

Nutrients ◽

10.3390/nu11010051 ◽

2018 ◽

Vol 11 (1) ◽

pp. 51 ◽

Cited By ~ 63

Author(s):

Jacobo de la Cuesta-Zuluaga ◽

Noel Mueller ◽

Rafael Álvarez-Quintero ◽

Eliana Velásquez-Mejía ◽

Jelver Sierra ◽

...

Keyword(s):

Risk Factors ◽

Gut Microbiota ◽

Disease Risk ◽

Community Dwelling ◽

Short Chain ◽

Gas Chromatography Mass Spectrometry ◽

Cardiometabolic Health ◽

Rrna Gene ◽

Gut Permeability ◽

Microbiota Diversity

Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.

Download Full-text

Identification of Robust Metabotypes Associated With Increased Cardiometabolic Disease Risk- an Approach for Improved Prevention Through Precision Nutrition

Current Developments in Nutrition ◽

10.1093/cdn/nzab044_035 ◽

2021 ◽

Vol 5 (Supplement_2) ◽

pp. 604-604

Author(s):

Marie Palmnäs-Bédard ◽

Viktor Skantze ◽

Agnetha Rastgaard-Hansen ◽

Johan Dicksved ◽

Jytte Halkjaer ◽

...

Keyword(s):

Physical Activity ◽

Gut Microbiota ◽

Disease Risk ◽

Risk Group ◽

Clustering Algorithms ◽

Cardiometabolic Disease ◽

Future Research ◽

Metabolomics Data ◽

Mean Values ◽

Cardiometabolic Disease Risk

Abstract Objectives We hypothesize that individuals can be grouped into robust metabolic phenotypes (metabotypes) based on biochemical, anthropometric, gut microbial and metabolomics data and that such metabotypes will reflect differences in cardiometabolic disease risk and can act as targets for tailored nutritional prevention. We furthermore hypothesize that diet-gut microbiota interactions will be major determinants of the metabotypes. Methods Metabotyping is currently performed based on baseline data from 628 Danish adults from a validation sub-study of the Danish Diet Cancer and Health-Next Generation cohort. Participants were followed for one year, also providing data at 6 and 12 months. Dietary data was obtained by food frequency questionnaire and repeated 24h recalls and data on physical activity, smoking, sociodemographic factors, disease prevalence and use of medication was collected by questionnaires. Untargeted metabolomics and gut microbiota are currently determined. Metabotypes will be identified using clustering algorithms, variable optimization and data integration of the plasma metabolome, the 16S rRNA microbiota and 14 biochemical and anthropometric variables. Differences in habitual diet and physical activity across metabotypes will be determined as well as main metabotype determinants and potential plasma metabolite biomarkers. We will also assess the reproducibility of the metabotypes and biomarkers over time. Results Two clusters of individuals were identified by using the currently available clinical and anthropometric data. One of the clusters presented with mean values consistent with overweight, hypertension and dyslipidemia. Next, we will integrate the plasma metabolomics and gut microbial data into the analysis to determine the metabotypes. Conclusions We have identified one higher risk group and one lower risk group for cardiometabolic disease and will identify and characterize metabotypes based on more extensive data. Future research will assess whether individuals belonging to different metabotypes respond differently to dietary interventions. Funding Sources Formas, Sweden.

Download Full-text

Neutral Effect of Increased Dairy Product Intake, as Part of a Lifestyle Modification Program, on Cardiometabolic Health in Adolescent Girls With Overweight/Obesity: A Secondary Analysis From a Randomized Controlled Trial

Frontiers in Nutrition ◽

10.3389/fnut.2021.673589 ◽

2021 ◽

Vol 8 ◽

Author(s):

Lauren E. Skelly ◽

Erin N. Barbour-Tuck ◽

Nigel Kurgan ◽

Melissa Calleja ◽

Panagiota Klentrou ◽

...

Keyword(s):

Risk Factors ◽

Lifestyle Modification ◽

Disease Risk ◽

Dairy Product ◽

Density Lipoprotein ◽

Cardiometabolic Disease ◽

Cardiometabolic Health ◽

Product Consumption ◽

Dairy Product Consumption ◽

Cardiometabolic Disease Risk

Background: The presence of obesity and some cardiometabolic disease risk factors in childhood and adolescence track into adulthood. Intake of dairy products has been shown to be inversely related to adiposity and cardiometabolic variables in youth. However, limited research has examined cardiometabolic disease risk factors following increased dairy product consumption as part of a lifestyle modification intervention in youth with overweight/obesity. This secondary analysis aimed to determine whether 12 weeks of increased dairy consumption, as part of a lifestyle modification program, affects cardiometabolic variables in adolescent females (range: 10–18 years) with overweight/obesity (BMI > 85th centile).Methods: Participants were randomized into two groups: higher dairy intake (RDa; four servings/day [to reflect previous Canada's Food Guide recommendations]; n = 23) or low dairy intake (LDa; 0–2 servings/day; n = 23). Both RDa and LDa participated in a 12-week, eucaloric, lifestyle modification intervention consisting of exercise training, and nutritional counseling. Adiposity (percent body fat [%BF]), dietary intake, and measures of cardiometabolic health were measured pre- and post-intervention.Results: There were no significant changes over time within groups or differences over time between groups for triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), TC/HDL ratio, low-density lipoprotein cholesterol (LDL), glucose, insulin, homeostatic model assessment of insulin resistance, adiponectin, and tumor necrosis factor alpha (TNF-α) (main effects of time and interactions, p > 0.05). Leptin decreased over the 12-week lifestyle intervention in both groups (main effect of time, p = 0.02). After combining the groups (n = 46), significant correlations were found between change in %BF and change in some cardiometabolic variables (HDL [r = −0.40], TC/HDL ratio [r = 0.42], LDL [r = 0.36], and TNF-α [r = 0.35], p < 0.05). After controlling for change in dairy product intake, the correlations were unchanged.Conclusion: Our findings demonstrate that increased dairy product consumption, as part of a lifestyle modification, weight management intervention, had a neutral effect on cardiometabolic disease risk factors in adolescent females with overweight/obesity. Change in dairy product intake did not influence the relationships between change in adiposity and change in cardiometabolic variables. Future research designed to primarily assess the effect of increased dairy product consumption on cardiometabolic disease risk factors in this population is warranted.Clinical Trial Registration:Clinicaltrials.gov; NCT#02581813.

Download Full-text

An Apple a Day Keeps the Doctor Away – Inter-Relationship Between Apple Consumption, the Gut Microbiota and Cardiometabolic Disease Risk Reduction

Diet-Microbe Interactions in the Gut ◽

10.1016/b978-0-12-407825-3.00012-5 ◽

2015 ◽

pp. 173-194 ◽

Cited By ~ 1

Author(s):

Athanasios Koutsos ◽

Julie A. Lovegrove

Keyword(s):

Gut Microbiota ◽

Risk Reduction ◽

Disease Risk ◽

Cardiometabolic Disease ◽

Cardiometabolic Disease Risk

Download Full-text

Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations

Global Heart ◽

10.1016/j.gheart.2017.01.011 ◽

2017 ◽

Vol 12 (2) ◽

pp. 141 ◽

Cited By ~ 20

Author(s):

Amy R. Bentley ◽

Charles N. Rotimi

Keyword(s):

Serum Lipids ◽

Disease Risk ◽

African Ancestry ◽

Cardiometabolic Disease ◽

Interethnic Differences ◽

Cardiometabolic Disease Risk

Download Full-text

Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors – ERRATUM

Psychological Medicine ◽

10.1017/s0033291719000291 ◽

2019 ◽

Vol 49 (10) ◽

pp. 1758-1758

Author(s):

Ragni H. Mørch ◽

Ingrid Dieset ◽

Ann Færden ◽

Elina J. Reponen ◽

Sigrun Hope ◽

...

Keyword(s):

Risk Factors ◽

Mental Disorders ◽

Inflammatory Markers ◽

Disease Risk ◽

Cardiometabolic Disease ◽

Severe Mental Disorders ◽

Cardiometabolic Disease Risk

Download Full-text

Distinct phenotypic characteristics of normal-weight adults at risk of developing cardiovascular and metabolic diseases

American Journal of Clinical Nutrition ◽

10.1093/ajcn/nqaa194 ◽

2020 ◽

Vol 112 (4) ◽

pp. 967-978

Author(s):

Abishek Stanley ◽

John Schuna ◽

Shengping Yang ◽

Samantha Kennedy ◽

Moonseong Heo ◽

...

Keyword(s):

Health Risk ◽

Body Shape ◽

Metabolic Diseases ◽

Disease Risk ◽

White Men ◽

Normal Weight ◽

Cardiometabolic Disease ◽

Men And Women ◽

Distinct Phenotype ◽

Cardiometabolic Disease Risk

ABSTRACT Background The normal-weight BMI range (18.5–24.9 kg/m2) includes adults with body shape and cardiometabolic disease risk features of excess adiposity, although a distinct phenotype developed on a large and diverse sample is lacking. Objective To identify demographic, behavioral, body composition, and health-risk biomarker characteristics of people in the normal-weight BMI range who are at increased risk of developing cardiovascular and metabolic diseases based on body shape. Methods Six nationally representative waist circumference index (WCI, weight/height0.5) prediction formulas, with BMI and age as covariates, were developed using data from 17,359 non-Hispanic (NH) white, NH black, and Mexican-American NHANES 1999–2006 participants. These equations were then used to predict WCI in 5594 NHANES participants whose BMI was within the normal weight range. Men and women in each race/Hispanic-origin group were then separated into high, medium, and low tertiles based on the difference (residual) between measured and predicted WCI. Characteristics were compared across tertiles; P values for significance were adjusted for multiple comparisons. Results Men and women in the high WCI residual tertile, relative to their BMI and age-equivalent counterparts in the low tertile, had significantly lower activity levels; higher percent trunk and total body fat (e.g. NH white men, X ± SE, 25.3 ± 0.2% compared with 20.4 ± 0.2%); lower percent appendicular lean mass (skeletal muscle) and bone mineral content; and higher plasma insulin and triglycerides, higher homeostatic model assessment of insulin resistance (e.g. NH white men, 1.45 ± 0.07 compared with 1.08 ± 0.06), and lower plasma HDL cholesterol. Percent leg fat was also significantly higher in men but lower in women. Similar patterns of variable statistical significance were present within sex and race/ethnic groups. Conclusions Cardiometabolic disease risk related to body shape in people who are normal weight according to BMI is characterized by a distinct phenotype that includes potentially modifiable behavioral health risk factors.

Download Full-text